Rhenovia Pharma, a new service pharmaceuticals and biotechnology company
We provide new solutions to discover new medicines against Alzheimer’s and other central nervous system (CNS) diseases by:
- developing breakthrough biosimulation platforms for Memory and other CNS functions
- developing service / partnership with pharma and biotech companies for the optimization of their drug discovery process
- offering unique opportunity to potential investors for large returns and exciting development perspectives
Rhenovia Pharma is the first CNS pharmaceutical company building its Drug Discovery strategy on modeling and simulation before experimental testing.